A five-year clinical genomics study, MAGIC-I, has been launched in Ireland with the aim to optimise childhood cancer care. The study will focus on better understanding how and why cancer develops, and also why patients experience different side effects and outcomes.
Dr Colm Henry, chief clinical officer of Ireland's Health Service Executive said the launch was a 'significant milestone in Irish cancer care'.
Read the PharmaTimes for more information.